TECHWIRE 30
(CIX: WRAL30)  1,112.75  down arrow-4.29  (-0.38 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: Apple)  101.66  up arrow+0.23  (0.23 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NY: QUINTILES)  57.57  down arrow-1.1  (-1.87 %)  Updated: 06:40 PM EDT, Sep 12 2014
(OP: BASF SE)  99.50  down arrow-0.22  (-0.22 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: BioCryst)  11.91  down arrow-0.33  (-2.7 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: BioDelivery)  18.15  up arrow+0.29  (1.62 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: CEMP)  10.01  down arrow-0.16  (-1.57 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: Cisco Systems)  25.16  down arrow-0.02  (-0.08 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: Cree)  42.68  down arrow-0.57  (-1.31 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: DARA)  1.17  down arrow-0.03  (-2.42 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NY: EMC CORPORATION)  29.65  down arrow-0.04  (-0.13 %)  Updated: 06:40 PM EDT, Sep 12 2014
(NQ: Extreme Networks)  5.19  down arrow-0.07  (-1.33 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: FB)  77.48  down arrow-0.44  (-0.56 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NY: GLAXOSMITHKLINE)  47.06  up arrow+0.13  (0.28 %)  Updated: 06:40 PM EDT, Sep 12 2014
(NQ: GOOG)  575.62  down arrow-5.73  (-0.99 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NY: IBM)  191.28  down arrow-0.44  (-0.23 %)  Updated: 06:40 PM EDT, Sep 12 2014
(NY: LH)  106.35  down arrow-0.92  (-0.86 %)  Updated: 06:40 PM EDT, Sep 12 2014
(OP: Lenovo Group)  31.50  up arrow+0.75  (2.44 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NY: MRK)  59.55  down arrow-0.55  (-0.92 %)  Updated: 06:40 PM EDT, Sep 12 2014
(NQ: Microsoft Corp)  46.70  down arrow-0.31  (-0.65 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: NTAP)  42.50  up arrow+0.04  (0.08 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NY: NOVARTIS AG)  93.76  down arrow-0.6  (-0.64 %)  Updated: 06:40 PM EDT, Sep 12 2014
(OP: Novozymes A/S)  44.91  down arrow-0.44  (-0.97 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NY: PFIZER)  29.43  down arrow-0.2  (-0.68 %)  Updated: 06:40 PM EDT, Sep 12 2014
(NQ: Pozen)  8.05  down arrow-0.27  (-3.25 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NY: RED HAT)  60.53  down arrow-1.15  (-1.86 %)  Updated: 06:40 PM EDT, Sep 12 2014
(NQ: BBRY)  10.79  up arrow+0.02  (0.14 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: Salix)  143.43  down arrow-5.56  (-3.73 %)  Updated: 08:10 PM EDT, Sep 12 2014
(NQ: SQI)  17.32  up arrow+0.12  (0.7 %)  Updated: 08:10 PM EDT, Sep 12 2014

Posts tagged “Biotech & Life Science”

1:10 p.m. Friday

UNC team gives Liberia boost in Ebola fight with website

A team of students and volunteers led by a UNC journalism professor is rendering aid to Liberia in that country's fight against Ebola with a new website designed to better coordinate the battle.

Tracking Ebola in Liberia Tracking Ebola in Liberia

12:54 p.m. Friday

Oxygen Bio stops drug trial, cites lack of patients

Drug trials Oxygen Biotherapeutics' proposed treatment to deliver oxygen to victims of stroke and traumatic brain injury, is halting the Phase 2 clinical trial. The firm says it has been unable to secure enough patients to participate in the trial.

10:07 a.m. Friday

FDA grants 'orphan' drug status to Viamet fungus fighter

Viamet Durham's Viamet Pharmaceuticals has been granted an orphan drug designation by the U.S. Food & Drug Administration for one of its lead drug candidates, an oral antifungal agent code-named VT-1129.

11:39 a.m. Thursday

Agriculture, biotech leaders to gather at NCSU for food 'summit'

AgBiotech Summit Food and agricultural experts from around the nation will join North Carolina peers at the McKimmon Conference Center in Raleigh Nov. 18 and 19 for a wide-ranging discussion of technologies and policies affecting food production.

4:39 p.m. Wednesday

Liquidia's spin-out cycle 2: Another new venture is born

Liquidia, itself spun out of the University of North Carolina at Chapel Hill in 2004 by superstar scientists Joe DeSimone and Ed Samulski, has "re-spun" its second new pharmaceutical company, this one to specifically target yet-undisclosed "oral health conditions."

The PRINT platform The PRINT platform

1:59 p.m. Tuesday

Chapel Hill drug firm Cempra receives $10M milestone payment

Cempra Completion of a phase 1 and launch of a phase 2 clinical trial in Japan for an antibiotic has earned Chapel Hill-based Cempra a $10 million milestone payment.

Updated 1:48 p.m. Tuesday

PRA Health Sciences files for $375M stock offering

PRA Health Sciences, which was taken private in a $1.3 billion deal a year ago, is looking to return to the public markets through a $375 million IPO.

PRA Health Sciences PRA Health Sciences

Updated 1:06 p.m. Tuesday

Sprout Pharmaceuticals lines up support in bid to win FDA approval for 'female Viagra'

More than 20 drugs are available to treat male sexual dysfunction, but never before has there been a pill for women. Sprout, a Raleigh-based pharmaceutical company, is hoping its little pink pill will be the first.

6:31 a.m. Tuesday

As Bayer CropScience breaks ground for $30M greenhouse, there's more growth to come

Jim Blome heads one of the world's largest seed companies, but he isn't ready to spill the beans on Bayer CropScience's future plans for expansion on its Research Triangle Park campus.

Rendering of Bayer CropScience's new RTP greenhouse Rendering of Bayer CropScience's new RTP greenhouse

6:26 a.m. Monday

News you may have missed: 40 headlines from last week

Week in review Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with more than 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

6:24 a.m. Monday

We want your news: Send company updates to WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

September 5

How to win grants: The 4 commandments for proposals

Research Grant It's no secret that research careers can thrive or die on grant funding. That's why it's always surprising to find bright people with advanced levels of education who just don't know how to make "the ask." Here is advice on how to win at writing grants.

September 3

Google, drug maker AbbVie invest $500M in health joint venture

Biotech Calico, a company created by Google last year, will manage a team of scientists who will work at a research-and-development lab in the San Francisco Bay Area. The precise location and size of the new lab hasn't been determined.

September 3

Plexus' new manager; Netflix tweaks recommendations; BioCryst defaults; Uber's roadblock

Bulldog In today's Bulldog wrapup blog of life science and technology news: Plexus Capital has a new leader; Netflix tweaks recommendations; a BioCryst default; and Uber is stopped in German:y

Updated September 3

Pappas to manage new venture fund from Chiesi Group

Venture Capital Durham-based venture capital firm A.M. Pappas & Associates will manage a new venture capital fund being launched by Italy-based Chiesi Ventures, the companies announced Tuesday.

Updated September 3

Xellia Pharma commits to $100M investment, 40 new jobs in Raleigh

Jobs  Lured in part by property tax incentives from the City of Raleigh, Xellia Pharmaceuticals will invest $100 million in the expansion of its manufacturing plant and create 40 new full-time jobs.

Updated September 2

Premium Lock Dignify Therapeutics wins SBIR grant, aims for $3M in funding

Dignify Therapeutics The drug development company focused on restoring bladder and bowel control to people with spinal injuries has been awarded $159,000 Small Business Innovation Research (SBIR) grant as global market potential for their flagship product continues to grow.

September 2

Holiday catch up: More than 50 WRAL TechWire headlines from last week

Week in review Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with more than 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

September 2

Your company making news? Share it with WRAL TechWire

Contribute to WRALTechWire WRAL TechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

August 30

Experimental Ebola drug heals all monkeys in study

Ebola fight   An experimental Ebola drug healed all 18 monkeys infected with the deadly virus in a study, boosting hopes that the treatment might help fight the outbreak raging through West Africa -- once more of it can be made.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll